US Patent 11858925 GAS41 inhibitors and methods of use thereof

Is a

Patent

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

118589250

Patent Inventor Names

Brian Linhares0

Jolanta Grembecka0

Tomasz Cierpicki0

Alyssa Winkler0

Dymytrii Listunov0

EunGi Kim0

Date of Patent

January 2, 2024

Patent Application Number

171599160

Date Filed

January 27, 2021

Patent Citations

‌

US Patent 6960563 Spontaneous emulsions containing cyclosporine

‌

US Patent 6946144 Transdermal delivery system

‌

US Patent 7030242 Selective inhibition of aggrecanase in osteoarthritis treatment

‌

US Patent 6923983 Transdermal delivery of hormones

‌

US Patent 6929801 Transdermal delivery of antiparkinson agents

Patent Primary Examiner

CPC Code

Patent abstract

Provided herein are small molecules that bind to GAS41 and inhibit GAS41 activity, and methods of use thereof for the treatment of cancer.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 11858925 GAS41 inhibitors and methods of use thereof

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 11858925 GAS41 inhibitors and methods of use thereof